Philadelphia’s Emergence as Life Sciences Hub Creates Mad Dash For Lab Space
By: Jamie Rash, Regional Director, Keystone Development + InvestmentTalk about a spark.When Spark Therapeutics announced plans at the end of last year to develop a $575 million gene therapy manufacturing plant in Philadelphia, it ignited the city’s evolution into a destination for the largest, most innovative life sciences firms in the world.Over $1 billion in venture capital (VC) investment is pouring into more than 50 Philadelphia life sciences companies that employ some 20,000 …